133 related articles for article (PubMed ID: 27142754)
1. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
Grabowska K; Puszko AK; Lipiński PF; Laskowska AK; Wileńska B; Witkowska E; Perret GY; Misicka A
Bioorg Med Chem; 2017 Jan; 25(2):597-602. PubMed ID: 27889287
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
[TBL] [Abstract][Full Text] [Related]
4. Conformational latitude - activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin-1.
Fedorczyk B; Lipiński PFJ; Tymecka D; Puszko AK; Wilenska B; Perret GY; Misicka A
J Pept Sci; 2017 Jun; 23(6):445-454. PubMed ID: 28466607
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
7. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
[TBL] [Abstract][Full Text] [Related]
8. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A
Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342
[TBL] [Abstract][Full Text] [Related]
9. N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
Jia H; Aqil R; Cheng L; Chapman C; Shaikh S; Jarvis A; Chan AW; Hartzoulakis B; Evans IM; Frolov A; Martin J; Frankel P; Djordevic S; Zachary IC; Selwood DL
Chembiochem; 2014 May; 15(8):1161-70. PubMed ID: 24771685
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
11. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-based peptidomimetics targeting neuropilin-1: Synthesis, molecular docking study and in vitro biological activities.
Richard M; Chateau A; Jelsch C; Didierjean C; Manival X; Charron C; Maigret B; Barberi-Heyob M; Chapleur Y; Boura C; Pellegrini-Moïse N
Bioorg Med Chem; 2016 Nov; 24(21):5315-5325. PubMed ID: 27622745
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.
Liu WQ; Megale V; Borriello L; Leforban B; Montès M; Goldwaser E; Gresh N; Piquemal JP; Hadj-Slimane R; Hermine O; Garbay C; Raynaud F; Lepelletier Y; Demange L
Bioorg Med Chem Lett; 2014 Sep; 24(17):4254-9. PubMed ID: 25091928
[TBL] [Abstract][Full Text] [Related]
14. Urea-Peptide Hybrids as VEGF-A
Puszko AK; Sosnowski P; Rignault-Bricard R; Hermine O; Hopfgartner G; Pułka-Ziach K; Lepelletier Y; Misicka A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374715
[TBL] [Abstract][Full Text] [Related]
15. NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model.
Liu WQ; Lepelletier Y; Montès M; Borriello L; Jarray R; Grépin R; Leforban B; Loukaci A; Benhida R; Hermine O; Dufour S; Pagès G; Garbay C; Raynaud F; Hadj-Slimane R; Demange L
Cancer Lett; 2018 Feb; 414():88-98. PubMed ID: 29111348
[TBL] [Abstract][Full Text] [Related]
16. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
[TBL] [Abstract][Full Text] [Related]
17. Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1.
Lee J; Kim E; Ryu SW; Choi C; Choi K
J Neurooncol; 2016 May; 128(1):29-34. PubMed ID: 26951556
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.
Tymecka D; Lipiński PFJ; Fedorczyk B; Puszko A; Wileńska B; Perret GY; Misicka A
Peptides; 2017 Aug; 94():25-32. PubMed ID: 28627371
[TBL] [Abstract][Full Text] [Related]
20. Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165.
Fedorczyk B; Lipiński PFJ; Puszko AK; Tymecka D; Wilenska B; Dudka W; Perret GY; Wieczorek R; Misicka A
Molecules; 2019 May; 24(9):. PubMed ID: 31064153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
